Related Experiment Videos
AML M1 and M2 with eosinophilia and AML M4Eo: diagnostic and clinical aspects
H Löffler1, W Gassmann, T Haferlach
1Department of Internal Medicine, University of Kiel, Germany.
Abstract:
AML with eosinophilia belongs to the morphologic cytogenetic entity M1/M2 t(8;21) with the involvement of the genes AML1/ETO. These eosinophils differ only slightly from normal eosinophils with one rare exception i.e. Auer rods in eosinophils which has only been found on peroxidase staining: This subtype belongs to the good prognosis group of AML. AML with inv(16) (mostly M4Eo) per se is a morphologic-cytogenetic entity with inv(16),--rarely t(16;16), and the genes MYL 11/CBF beta involved. The eosinophils show special abnormalities. AML with inv(16) also belongs to the good prognosis group of AML.
Insights
Acute myeloid leukemia (AML) subtypes with eosinophilia, specifically t(8;21) and inv(16), are linked to favorable prognoses. These subtypes involve specific gene mutations and characteristic eosinophil abnormalities.
Area of Science:
- Hematology
- Oncology
- Cytogenetics
Background:
- Acute myeloid leukemia (AML) encompasses diverse subtypes with varying prognoses.
- Eosinophilia in AML can indicate specific genetic and morphologic entities.
- Certain AML subtypes with eosinophilia are associated with a favorable prognosis.
Purpose of the Study:
- To detail the morphologic and cytogenetic characteristics of AML with eosinophilia.
- To highlight the prognostic implications of specific genetic mutations in these AML subtypes.
- To describe the unique features of eosinophils in AML with eosinophilia.
Main Methods:
- Morphologic analysis of bone marrow aspirates.
- Cytogenetic analysis to identify specific chromosomal translocations (e.g., t(8;21), inv(16)).
- Genetic analysis for gene involvement (e.g., AML1/ETO, MYH11/CBFB).
- Peroxidase staining for Auer rod detection in eosinophils.
Main Results:
- AML with t(8;21) involves AML1/ETO genes and shows minimal eosinophil deviation, with rare Auer rods.
- AML with inv(16) involves MYH11/CBFB genes and presents with distinct eosinophil abnormalities.
- Both AML subtypes, t(8;21) and inv(16) with eosinophilia, are classified within the good prognosis group of AML.
Conclusions:
- AML with eosinophilia, particularly subtypes t(8;21) and inv(16), represents distinct morphologic-cytogenetic entities.
- These subtypes are characterized by specific genetic alterations and eosinophil abnormalities.
- The presence of eosinophilia in these AML subtypes is indicative of a favorable clinical outcome.